Article: Two European approvals of alitretinoin for hand eczema

Article from:
Inpharma Weekly
Article date:
October 25, 2008
Author:
Copyright

Basilea Pharmaceutica's alitretinoin [Tortino], a oncedaily oral treatment for adults with severe chronic hand eczema unresponsive to potent topical corticosteroids, has received national regulatory approvals in both France and Finland.1·2

[Reference]

1. Basilea Pharmaceutica Ltd. Basilea's Toctino (Rm) ...

Read all of this article with a FREE trial

Related newspaper, magazine, and journal articles:

Article: Basilea Pharmaceutica - Corporate and Strategic ...
M2 Presswire;  September 26, 2008 ;     700+ words ... ... www.companiesandmarkets.com: Basilea Pharmaceutica - Corporate and Strategic Assessment ... companiesandmarkets.com adds new report: Basilea Pharmaceutica - Corporate and Strategic Assessment ... Strategy, SWOT Analysis Introduction Basilea Pharmaceutica (Basilea) is a ...

Article: Basilea Pharmaceutica AG - Therapeutic Competitors.
M2 Presswire;  June 22, 2009 ;     700+ words ... ... Companies and Markets: Basilea Pharmaceutica AG - Therapeutic Competitors ... COMMUNICATIONS RDATE:22062009 Basilea Pharmaceutica AG - Therapeutic Competitors ... and Market Analysis 'Basilea Pharmaceutica AG - Therapeutic Competitors ...

Article: Basilea Pharmaceutica AG-Detailed Product Pipeline.
M2 Presswire;  March 11, 2009 ;     572 words ... ... PRESSWIRE-11 March 2009-www.companiesandmarkets.com: Basilea Pharmaceutica AG-Detailed Product Pipeline(C)1994-2009 M2 COMMUNICATIONS ... 11032009 -www.companiesandmarkets.com adds new report: Basilea Pharmaceutica AG-Detailed Product Pipeline Pipeline Reports contain ...

Article: Basilea Pharmaceutica AG-Financial Company Report.
M2 Presswire;  February 12, 2009 ;     700+ words ... ... 12 February 2009-www.companiesandmarkets.com: Basilea Pharmaceutica AG-Financial Company Report(C)1994-2009 M2 COMMUNICATIONS ... 12022009 -www.companiesandmarkets.com adds new report: Basilea Pharmaceutica AG-Financial Company Report Financial Company Reports ...

Article: Basilea Pharmaceutica AG-Therapeutic Competitors.
M2 Presswire;  January 29, 2009 ;     700+ words ... ... 29 January 2009-www.companiesandmarkets.com: Basilea Pharmaceutica AG-Therapeutic Competitors(C)1994-2009 M2 COMMUNICATIONS ... 29012009 -www.companiesandmarkets.com adds new report: Basilea Pharmaceutica AG-Therapeutic Competitors Therapeutic Competitors ...

Article: Basilea Pharmaceutica.
Chemistry and Industry;  November 6, 2000 ;     465 words ...Roche has created an independent biotechnology company, Basilea Pharmaceutica, specialising in research into skin diseases and infectious diseases.

Article: Basilea Pharmaceutica names SCO and CTO.(Jutta Heim ...
Pharma Marketletter;  March 1, 2004 ;     495 words ...Jutta Heim and Ingrid Heinze-Krauss have been appointed as chief scientific officer and chief technology officer of the Swiss company Basilea Pharmaceutica. Prof Heim was previously head of the Novartis lead discovery center.

Article: Basilea Pharmaceutica AG, a Swiss biotechnology ...
MondayMorning;  February 26, 2007 ;     700+ words ...Basilea Pharmaceutica AG, a Swiss biotechnology company, said an experimental drug helped relieve patients with a chronic skin disease and will be ...

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!

Find articles, research, and archives